At Novo Nordisk, patient safety is paramount. We are the only company in the United States with FDA-approved medications containing semaglutide. No generic or other alternate FDA-approved products containing semaglutide currently exist. Read more here.
Updated: June 16, 2023
Novo Nordisk is working with the US Food and Drug Administration (FDA) and is alerting the public that a counterfeit case of Ozempic® (semaglutide injection) pen was found in the US. The safety or efficacy of counterfeit products is unknown and they should not be used. Potential risks of taking a counterfeit medicine include serious adverse events.
For pictures and details to identify differences between an authentic FDA-approved Ozempic® pen in the US and counterfeit product,